Breakthroughs from two rival experiments, Germany’s Wendelstein 7-X and the Joint European Torus, suggest the elusive dream ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

With more than a decade of productive partnership in advancing high-power laser technology, Lawrence Livermore National ...

“We are looking forward to expanding our existing collaborations with ELI on areas such as ultrabright high-repetition-rate ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

Lawrence Livermore National Lab will be able to use Claude to wrangle large datasets, generate scientific hypotheses and more ...

The US' Lawrence Livermore National Laboratory (LLNL) has partnered with Amazon Web Services (AWS) for an AI-driven troubleshooting and reliability system at LLNL's National Ignition Facility (NIF).

A new algorithm helps topology optimizers skip unnecessary iterations, making optimization and design faster, more stable and ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Oklo Inc. (NYSE:OKLO) is one of the top 10 nuclear energy stocks to invest in for the next decade. On June 25, the company ...

A paper on fusion neutron sources by a team from the United States of America’s Lawrence Livermore National Laboratory and the University of Rochester has won the IAEA’s annual Nuclear Fusion prize.